By Andrew Dunn
Publication Date: 2026-01-20 12:00:00
Google DeepMind spinout Isomorphic Labs has closed its third pharmaceutical deal.
The AI-focused biotech company has signed a multi-target research agreement with Johnson & Johnson…
Sign in to read this article for free.
Get free access to a limited number of articles and choose newsletters delivered straight to your inbox.
